GlaxoSmithKline News

Carcinogen Worry Causes Generic Zantac Recall at U.S. Pharmacies

Some generic Zantac is being pulled from major chain pharmacies in the U.S. shortly after French officials recalled all versions of the popular stomach drug amid a global investigation into a carcinogen found in the pills. Canadian drugmaker Apotex Inc. …

GlaxoSmithKline Agrees to $3B Settlement with U.S.

GlaxoSmithKline PLC has agreed in principle with the U.S. government on a $3 billion settlement of investigations into the company’s sales and marketing practices, the drug maker said Thursday. The agreement is expected to be completed next year, and the …